Allstate Investment Management’s West Pharmaceutical WST Stock Holding History

Allstate Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$992K	Buy	+4,217	New	+$999K	0.03%	353

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allstate Investment Management's WST Position: Q4 2022 in Review

Allstate Investment Management opened a new position in West Pharmaceutical (WST) in Q4 2022: 4,217 shares worth $992K. The stake represents 0.03% of the portfolio and ranks #353 among its holdings.

637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

Allstate Investment Management held 4,217 shares of West Pharmaceutical worth $992K as of Q4 2022.
West Pharmaceutical was a new Allstate Investment Management position in Q4 2022.
West Pharmaceutical made up 0.03% of Allstate Investment Management's portfolio in Q4 2022, its #353 holding.
637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.